TIANJIN Zhong Xin Pharmaceutical Group Corp's controlling shareholder plans to carry out a mixed-ownership reform amid a Communist drive to reform state-owned enterprises, the Singapore-listed firm said on Tuesday.
Register to read this article. Log in if you are already a subscriber.Register to read this article. Log in if you are already a subscriber.Please log in or subscribe to continue reading.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes